Advertisement

Related Videos

The Interventional Pharmacoeconomic Toolbox Panel Discussion

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

Mark J. Ratain, MD: The Justification for a Randomized Trial of Low-Dose Ibrutinib

Sarah Yim, MD, on Clinical Development of Biosimilars: Lessons for Interventional Pharmacoeconomics

Advertisement

Advertisement




Jun
25
Today In Oncology
Early Palliative Care Improves Quality of Life for Patients With Breast Cancer in India
Breast Cancer Palbociclib-Based Regimen Approved for HR-Positive, HER2-Positive Metastatic Disease
Advanced Breast Cancer Novel CDK4/6 Inhibitor Plus an Aromatase Inhibitor
FDA Approves Sacituzumab Govitecan-hziy as Monotherapy and in Combination With Pembrolizumab for First-Line Treatment of TNBC
Educational Gaps Found in Cardio-Oncology Training
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo